VIBIOSPHEN is a French privately-owned and independent company specialized in infectious diseases (bacteria – virus – fungi). Vibiosphen offers R&D preclinical services to support each step of the target product profile (TPP) definition: from identifying the right indication and defining the in vitro efficacy of the product to proving the safety of the molecule and determining the dose or route of administration.

MIC – MBC – TKC – Cytotoxicity – MTD – PK/PD – In Vivo Efficacy

Model efficacy (mice)

✓ Gastro-intestinal infection

✓ Urinary tract infection: pyelonephritis, acute & chronic diseases

✓ Tuberculosis acute & chronic diseases

✓ Pulmonary single & co-infection

✓ Skin infection

✓ Thigh infection

✓ Septicemia

✓ on demand model establishment